Ana is a molecular biologist enthusiastic about innovation and communication. In her role as a science writer she wishes to bring the advances in medical science and technology closer to the public, particularly to those most in need of them. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she focused her research on molecular biology, epigenetics and infectious diseases.
Asthma is a common cause and complication of bronchiectasis, triggering the disease in about one quarter of patients who live in Helsinki, Finland’s capital, a registry-based study found. Patients ... Read more
NEATstik, a test developed by ProAxsis, shows potential as a quick tool for assessing bronchiectasis severity, the presence of airway infections, and the risk of future disease exacerbations, early data ... Read more
The U.S. Food and Drug Administration (FDA) has stood by its initial refusal to approve Apulmiq for the treatment of non-cystic fibrosis bronchiectasis (NCFBE) associated with chronic Pseudomonas aeruginosa lung infection. The agency ... Read more
An abundance of Pseudomonas aeruginosa bacteria in the airways of patients with non-cystic fibrosis (CF) bronchiectasis is linked to greater inflammation by dampening expression of a gene called PPARγ, ... Read more
A lung transplant can benefit patients with non-cystic fibrosis bronchiectasis at advanced stages, and should be considered by physicians as a therapeutic option, a study found. Findings show that lung ... Read more
Bronchiectasis in chronic obstructive pulmonary disease (COPD) patients is associated with a notably higher risk of acute respiratory flares and other serious problems, a Taiwan study shows, and its researchers emphasized ... Read more
Pin It on Pinterest